Active substance | Pritelivir |
Holder | myTomorrows |
Status | Running |
Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
Public documents | |
Last update | 12/03/2024 |
Active substance | Pritelivir |
Holder | myTomorrows |
Status | Running |
Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
Public documents | |
Last update | 12/03/2024 |